Three insights:
- Investments in the sector reached $23.8 billion across 556 completed transactions, according to the report, which is based on data covering the first nine months of 2021.
- Aggregate expansion-stage deal value more than doubled between 2019 and 2020, rising from $8.3 billion to $17.4 billion.
- The median age of a health technology company at the time of its expansion-stage deal has never been lower, at 7.4 years.
